The Hoosier Moms Cohort

Age
18 years - 100 years
Gender
Female
Phase
Phase 1
The Hoosier Moms Cohort Check your eligibility

Brief description of study

The purpose of this study is to better understand how Gestational Diabetes Mellitus (GDM, high blood sugar in pregnancy) develops. We hope to understand the differences between women who are diagnosed with GDM and those who are not. Another purpose is to understand how GDM can progress to Type 2 Diabetes after the baby is born. We also hope to learn about infants born to mothers with GDM compare to infants born to mothers not diagnosed with GDM.
 
This study is taking place currently in Indianapolis, Bloomington, and Evansville, Indiana. 

Detailed description of study

As part of Indiana University Grand Challenges Precision Health Initiative Diabetes Team, this prospective cohort study seeks to better understand and identify differences in women who develop gestational diabetes mellitus (GDM) between those who don't.
 
Participants will be asked to come for up to 5 in person visits; three during pregnancy and two after you deliver your baby.  At these visits, participants will be asked to provide blood and urine, answer questions about their pregnancy and health, and take surveys.  Participants will be given an activity monitor to wear (like a Fitbit) and will be asked to download a nutrition app to take photos of what they eat.
 
 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: gestational diabetes mellitus,pregnancy,diabetes,gestational diabetes,pregnant,mom,type 1,type I,type 2,type II,hoosier mom,hoosier,mom,pregnancy study,
  • Age: 18 years - 100 years
  • Gender: Female

Inclusion Criteria
Pregnant with one child
Less than 20 weeks pregnant
 
Exclusion Criteria
 Current diagnosis of Type 1 or Type 2 Diabetes Mellitus
 
 
 

Updated on 29 Sep 2026. Study ID: 1808964513

Pre-Screener

Consent Check if you are eligible Update Enter contact details Select a study center Select best time to contact

Informed consent
Introduction
You are being asked to participate in a research study. Before you decide to participate in this study, it is important that you understand why the research is being done and what it will involve. This form is designed to give you the information about the study so you can decide whether to be in the study or not. Please take the time to read the following information carefully. You should ask the researcher if there is anything that is not clear or if you need more information.
Study Participation
If you agree to participate in this study, you will be asked to:
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team
  • If you agree to participate in this study, you will be asked to:
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team
  • If you agree to participate in this study, you will be asked to:
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team
  • If you agree to participate in this study, you will be asked to:
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team
  • If you agree to participate in this study, you will be asked to:
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team

Preview complete

The prescreener preview is complete. You may now close the preview.

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team